Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Skin stem cells are maintained by signals from nearby cells and vary in their ability to renew and mature.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

The drug combination was safe and showed promise in treating advanced tumors.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Platelet-rich plasma shows potential for hair loss and skin rejuvenation but needs more research for widespread use.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.

New treatments for hair loss show promise, but more development is needed, especially for tough cases.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Anifrolumab significantly improved skin lesions and hair regrowth in severe discoid lupus.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Bardet-Biedl syndrome may include under-recognized skin problems related to its metabolic disturbances.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

The rash resolved after stopping ponatinib.

The CTLA-4 gene change studied does not affect Polycystic Ovarian Syndrome in the women tested.

Platelet-rich plasma injections can effectively treat stubborn alopecia areata.

The document concludes that specific hair and blood vessel abnormalities in infants with seizures and developmental issues may indicate Menkes disease, which lacks a cure and is often fatal by age 3.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

GnRH analogues are effective for diagnosing and treating female androgen excess, offering a non-surgical option.

DCPA is a chronic skin condition affecting the legs, often misdiagnosed, and needs more research for better understanding and treatment.

Finasteride may help treat hidradenitis suppurativa in children, but concerns exist about ethics, safety, and proper use.

IVIG therapy was linked to hair regrowth in two patients with hair loss, but it's not recommended due to its risks and costs.

Treating acute myeloid leukemia is challenging, especially in older adults, despite some advancements.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Minoxidil can cause a rare but serious condition that leads to fluid buildup around the heart and drug-induced lupus.